455 related articles for article (PubMed ID: 25933380)
1. Prognostic impact of reduced connexin43 expression and gap junction coupling of neoplastic stromal cells in giant cell tumor of bone.
Balla P; Maros ME; Barna G; Antal I; Papp G; Sapi Z; Athanasou NA; Benassi MS; Picci P; Krenacs T
PLoS One; 2015; 10(5):e0125316. PubMed ID: 25933380
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
[TBL] [Abstract][Full Text] [Related]
3. Stromal Cell-Derived CCL20 Promotes Tumor Progression and Osteolysis in Giant Cell Tumor of Bone.
Zhao C; Wang D; Tang L; Zhang Z; Li S; Qian M; Wu Z; Zhou W; Liu M; Luo J; Liu T; Li Z; Xiao J
Cell Physiol Biochem; 2018; 51(5):2472-2483. PubMed ID: 30537747
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
[TBL] [Abstract][Full Text] [Related]
5. Gap junctional communication in human osteoclasts in vitro and in vivo.
Schilling AF; Filke S; Lange T; Gebauer M; Brink S; Baranowsky A; Zustin J; Amling M
J Cell Mol Med; 2008 Dec; 12(6A):2497-504. PubMed ID: 18266960
[TBL] [Abstract][Full Text] [Related]
6. Autosomal recessive GJA1 (Cx43) gene mutations cause oculodentodigital dysplasia by distinct mechanisms.
Huang T; Shao Q; MacDonald A; Xin L; Lorentz R; Bai D; Laird DW
J Cell Sci; 2013 Jul; 126(Pt 13):2857-66. PubMed ID: 23606748
[TBL] [Abstract][Full Text] [Related]
7. ODDD-linked Cx43 mutants reduce endogenous Cx43 expression and function in osteoblasts and inhibit late stage differentiation.
McLachlan E; Plante I; Shao Q; Tong D; Kidder GM; Bernier SM; Laird DW
J Bone Miner Res; 2008 Jun; 23(6):928-38. PubMed ID: 18269311
[TBL] [Abstract][Full Text] [Related]
8. Fate of connexin43 in cardiac tissue harbouring a disease-linked connexin43 mutant.
Manias JL; Plante I; Gong XQ; Shao Q; Churko J; Bai D; Laird DW
Cardiovasc Res; 2008 Dec; 80(3):385-95. PubMed ID: 18678643
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-9 expression of GCTSC in peripheral tissue and central tissue of GCTB.
Chen L; Zhang J; He Y; Ding XY
J Cell Biochem; 2018 Jul; 119(7):5805-5812. PubMed ID: 29600575
[TBL] [Abstract][Full Text] [Related]
10. H3F3A G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors.
Gong L; Bui MM; Zhang W; Sun X; Zhang M; Yi D
Histol Histopathol; 2021 Jan; 36(1):61-68. PubMed ID: 33021329
[TBL] [Abstract][Full Text] [Related]
11. Norcantharidin modulates the miR-30a/Metadherin/AKT signaling axis to suppress proliferation and metastasis of stromal tumor cells in giant cell tumor of bone.
Chen F; Wang S; Wei Y; Wu J; Huang G; Chen J; Shi J; Xia J
Biomed Pharmacother; 2018 Jul; 103():1092-1100. PubMed ID: 29710674
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor signalling contributes to osteoblastic stromal cell proliferation, osteoclastogenesis and disease progression in giant cell tumour of bone.
Balla P; Moskovszky L; Sapi Z; Forsyth R; Knowles H; Athanasou NA; Szendroi M; Kopper L; Rajnai H; Pinter F; Petak I; Benassi MS; Picci P; Conti A; Krenacs T
Histopathology; 2011 Sep; 59(3):376-89. PubMed ID: 22034878
[TBL] [Abstract][Full Text] [Related]
13. Serglycin induces osteoclastogenesis and promotes tumor growth in giant cell tumor of bone.
He Y; Cheng D; Lian C; Liu Y; Luo W; Wang Y; Ma C; Wu Q; Tian P; He D; Jia Z; Lv X; Zhang X; Pan Z; Lu J; Xiao Y; Zhang P; Liang Y; Yang Q; Hu G
Cell Death Dis; 2021 Sep; 12(10):868. PubMed ID: 34556636
[TBL] [Abstract][Full Text] [Related]
14. IL-17A stimulates the progression of giant cell tumors of bone.
Xu M; Song ZG; Xu CX; Rong GH; Fan KX; Chen JY; Zhang W; Jia JP; Han G; Wang W; Chai W; Liang WT; Bi WZ; Wang Y
Clin Cancer Res; 2013 Sep; 19(17):4697-705. PubMed ID: 23857601
[TBL] [Abstract][Full Text] [Related]
15. Genome-Wide Transcriptome Profiling of the Neoplastic Giant Cell Tumor of Bone Stromal Cells by RNA Sequencing.
Lau CP; Kwok JS; Tsui JC; Huang L; Yang KY; Tsui SK; Kumta SM
J Cell Biochem; 2017 Jun; 118(6):1349-1360. PubMed ID: 27862217
[TBL] [Abstract][Full Text] [Related]
16. Connexin43 Mutant Patient-Derived Induced Pluripotent Stem Cells Exhibit Altered Differentiation Potential.
Esseltine JL; Shao Q; Brooks C; Sampson J; Betts DH; Séguin CA; Laird DW
J Bone Miner Res; 2017 Jun; 32(6):1368-1385. PubMed ID: 28177159
[TBL] [Abstract][Full Text] [Related]
17. Oculodentodigital dysplasia connexin43 mutations result in non-functional connexin hemichannels and gap junctions in C6 glioma cells.
Lai A; Le DN; Paznekas WA; Gifford WD; Jabs EW; Charles AC
J Cell Sci; 2006 Feb; 119(Pt 3):532-41. PubMed ID: 16418219
[TBL] [Abstract][Full Text] [Related]
18. Connexin43 gap junctions in normal, regenerating, and cultured mouse bone marrow and in human leukemias: their possible involvement in blood formation.
Krenacs T; Rosendaal M
Am J Pathol; 1998 Apr; 152(4):993-1004. PubMed ID: 9546360
[TBL] [Abstract][Full Text] [Related]
19. Histomorphometric Analysis of Pre- and Post-Denosumab-Treated Giant Cell Tumor of Bone.
Ud Din N; Umer M; Park YK
Int J Surg Pathol; 2020 Dec; 28(8):859-867. PubMed ID: 32429739
[No Abstract] [Full Text] [Related]
20. Giant cell tumor of bonelike lesion in a Trp53 mutant mouse.
Radaelli E; Rustighi A; Scanziani E
Toxicol Pathol; 2012 Jun; 40(4):675-81. PubMed ID: 22328409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]